The use of funds from proceeds for HEAL Smart Impact Bond Series ABC and M up to $30.5 billion are expected to be used to fund research and development (R&D) and synergistic strategies with Immunotherapy Cure Centers at participating institutions, for the mission:

  • 33% for HIV Cure and Vaccine R&D and Eradication Proofs-of-Concept
  • 33% for Cancer Immunotherapy R&D
  • 33% for Advanced Cancer Diagnostics, Prevention and Monitoring

NOT AN OFFER TO INVEST. See Informational Memorandum and Prospectus.